keyword
https://read.qxmd.com/read/38007049/demystifying-the-global-outbreak-of-severe-acute-hepatitis-of-unknown-aetiology-in-children-a-systematic-review-and-meta-analysis
#41
JOURNAL ARTICLE
Julie Phan, Guy D Eslick, Elizabeth J Elliott
BACKGROUND: The sudden outbreak of severe acute hepatitis of unknown aetiology (SAHUA) in the first half of 2022 affected more than 1010 children in 35 countries worldwide. Dire clinical outcomes, such as acute liver failure necessitating transplantation, neurological symptoms, long-term sequelae, and death, highlight the need to determine the pathogenesis of this condition. Hypotheses on the aetiology include adenovirus and SARS-CoV-2 infections and an aberrant immune response to multiple pathogen exposure following lifting of lockdown measures but further investigation is required to reach an informed consensus...
January 2024: Journal of Infection
https://read.qxmd.com/read/37996345/efficacy-of-therapeutic-plasma-exchange-in-pediatric-cases-of-acute-liver-failure-as-an-extracorporeal-liver-support-system
#42
JOURNAL ARTICLE
Mohit Chowdhry, Ankita Sharma, Soma Agrawal, Rohit Vohra, Karunesh Kumar, Neerav Goyal, Arun Kumar V, Nameet Jerath, Smita Malhotra, Anupam Sibal, Manoj Mishra
BACKGROUND: Acute liver failure in the pediatric population is often accompanied by deranged metabolism, severe encephalopathy and coagulopathy. A liver transplant is the most viable option for the management of such patients. Therapeutic plasma exchange (TPE) is helpful in improving the liver biochemistry profile, thereby, increasing their likelihood of undergoing a liver transplant METHOD: The study was conducted over a period of 3 years (January 2018 to December 2021). Indications mainly consisted of ALF with hepatic encephalopathy, worsening liver parameters in spite of medical management, and candidacy for undergoing a liver transplant...
October 21, 2023: Transfusion and Apheresis Science
https://read.qxmd.com/read/37980196/hepatic-metastasectomy-in-pediatric-patients-an-observational-study
#43
JOURNAL ARTICLE
Andrew M Fleming, Sara A Mansfield, Tim Jancelewicz, Ankush Gosain, James W Eubanks, Andrew M Davidoff, Max R Langham, Andrew J Murphy
BACKGROUND: The role of hepatectomy for metastatic disease in children is controversial. Rationales include potential cure, obtaining a diagnosis, and guiding chemotherapy decisions. This study examines the safety and utility of hepatic metastasectomy for children at a single institution. METHODS: After IRB approval (#22-1258), medical records were reviewed from 1995 to 2022 for children undergoing hepatic metastasectomy. En-bloc hepatectomies during primary tumor resection were excluded...
October 23, 2023: Journal of Pediatric Surgery
https://read.qxmd.com/read/37977713/safety-and-efficacy-of-gene-replacement-therapy-for-x-linked-myotubular-myopathy-aspiro-a-multinational-open-label-dose-escalation-trial
#44
RANDOMIZED CONTROLLED TRIAL
Perry B Shieh, Nancy L Kuntz, James J Dowling, Wolfgang Müller-Felber, Carsten G Bönnemann, Andreea M Seferian, Laurent Servais, Barbara K Smith, Francesco Muntoni, Astrid Blaschek, A Reghan Foley, Dimah N Saade, Sarah Neuhaus, Lindsay N Alfano, Alan H Beggs, Ana Buj-Bello, Martin K Childers, Tina Duong, Robert J Graham, Minal Jain, Julie Coats, Vicky MacBean, Emma S James, Jun Lee, Fulvio Mavilio, Weston Miller, Fatbardha Varfaj, Michael Murtagh, Cong Han, Mojtaba Noursalehi, Michael W Lawlor, Suyash Prasad, Salvador Rico
BACKGROUND: X-linked myotubular myopathy is a rare, life-threatening, congenital muscle disease observed mostly in males, which is caused by mutations in MTM1. No therapies are approved for this disease. We aimed to assess the safety and efficacy of resamirigene bilparvovec, which is an adeno-associated viral vector serotype 8 delivering human MTM1. METHODS: ASPIRO is an open-label, dose-escalation trial at seven academic medical centres in Canada, France, Germany, and the USA...
December 2023: Lancet Neurology
https://read.qxmd.com/read/37970614/challenges-and-dilemmas-in-pediatric-hepatic-wilson-s-disease
#45
REVIEW
Upasana Ghosh, Moinak Sen Sarma, Arghya Samanta
Wilson disease is an autosomal recessive disorder affecting the ATP7B gene located on chromosome 13q. This leads to copper deposition in various organs, most importantly in the liver and brain. The genetic mutations are vast, well reported in the West but poorly documented in developing countries. Hence the diagnosis is made with a constellation of clinico-laboratory parameters which have significant overlap with other liver diseases and often pose a significant dilemma for clinicians. Diagnostic scoring systems are not fool-proof...
October 27, 2023: World Journal of Hepatology
https://read.qxmd.com/read/37965976/the-role-of-liver-transplantation-in-coach-syndrome-joubert-syndrome-with-congenital-hepatic-fibrosis-a-review-of-the-literature
#46
JOURNAL ARTICLE
Lijian Chen, Hajime Uchida, Ryuji Komine, Tasuku Kodama, Toshimasa Nakao, Noriki Okada, Yusuke Yanagi, Seiichi Shimizu, Syed Abbas, Akinari Fukuda, Seisuke Sakamoto, Mureo Kasahara
BACKGROUND: COACH syndrome is a rare autosomal recessive genetic disease characterized by liver fibrosis, which leads to severe complications related to portal hypertension. However, only a few patients with COACH syndrome undergoing liver transplantation (LT) have been reported. MATERIALS AND METHODS: We herein report the outcomes of four children who underwent LT for COACH syndrome at our institute and review three previously reported cases to elucidate the role of LT in COACH syndrome...
November 15, 2023: Pediatric Transplantation
https://read.qxmd.com/read/37936530/outcome-of-pediatric-living-donor-liver-transplant-experience-from-pakistan-a-resource-limited-setting
#47
JOURNAL ARTICLE
Sahira Aaraj, Sabeen Abid Khan, Fatima Maroof, Syed Zohaib Hussain, Faisal Saud Dar, Munir Iqbal Malik
INTRODUCTION: Liver transplantation (LT) has emerged as a lifesaving modality for many liver diseases in children. Pediatric LT is an established treatment in the Western world but is relatively a new procedure in resource-limited countries like Pakistan. The study aims to highlight the outcomes and survival of pediatric recipients from the first pediatric liver transplant center in Pakistan. METHOD: A retrospective analysis of pediatric LT was done from 2012 to 2019...
November 7, 2023: Pediatric Transplantation
https://read.qxmd.com/read/37916829/severe-methotrexate-toxicity-following-a-capizzi-cycle-in-an-obese-adolescent-with-acute-lymphoblastic-leukemia-and-hepatic-steatosis
#48
JOURNAL ARTICLE
Julie M Fischer, Oranooj Lertkovit, Scott C Howard, Chatchawin Assanasen, Archie Bleyer
Methotrexate is a major component of pediatric leukemia treatment. While toxicities are common after high-dose methotrexate, escalating dose methotrexate (Capizzi methotrexate) is typically well-tolerated. We report an adolescent Hispanic female with pre-B acute lymphoblastic leukemia, preexisting obesity and hepatic steatosis who developed severe multiorgan failure following an escalating dose of methotrexate with delayed methotrexate excretion of 11 days. We identified one similar report in an obese adult; however, this case is the first to our knowledge involving a pediatric patient...
January 1, 2024: Journal of Pediatric Hematology/oncology
https://read.qxmd.com/read/37880024/liver-transplantation-for-acute-liver-failure-due-to-yellow-phosphorus-poisoning-a-comprehensive-review
#49
JOURNAL ARTICLE
Hirak Pahari, Amruth Raj, Amey Sonavane, Ambreen Sawant, Deepak Kumar Gupta, Amit Gharat, Vikram Raut
Yellow phosphorus or metal phosphide (YP-MP) rodenticide poisoning has been a known cause of acute liver failure (ALF) in many countries of Asia and North and South America over the last decade. It is a highly toxic compound and is a well-known cause of intentional or accidental poisoning in both adults and children. In lower doses, it causes gastrointestinal symptoms and mild hepatic injury, and patients may spontaneously recover. In higher doses, hepatic necrosis and fatty infiltration may cause significant injury and may even lead to ALF, characterized by hepatic encephalopathy, coagulopathy, and lactic acidosis...
October 23, 2023: Transplantation Proceedings
https://read.qxmd.com/read/37837969/acute-liver-failure-in-low-income-and-middle-income-countries
#50
REVIEW
Sandro Vento, Francesca Cainelli
Acute liver failure is a rare condition involving the rapid development, progression, and worsening of liver dysfunction, characterised by coagulopathy and encephalopathy, and has a high mortality unless liver transplantation is performed. Population-based studies are scarce, and most published data are from high-income countries, where the main cause of acute liver failure is paracetamol overdose. This Review provides an overview of the scanty literature on acute liver failure in low-income and middle-income countries, where patients are often admitted to primary care hospitals and viral hepatitis (especially hepatitis E), tropical infections (eg, dengue), traditional medicines, and drugs (especially anti-tuberculosis drugs) have an important role...
November 2023: Lancet. Gastroenterology & Hepatology
https://read.qxmd.com/read/37831217/current-endovascular-management-of-arterial-complications-after-pediatric-liver-transplantation-in-a-tertiary-center
#51
JOURNAL ARTICLE
Paolo Marra, Riccardo Muglia, Carlo Alberto Capodaglio, Ludovico Dulcetta, Francesco Saverio Carbone, Naire Sansotta, Domenico Pinelli, Antonio Celestino, Giuseppe Muscogiuri, Ezio Bonanomi, Stefano Fagiuoli, Lorenzo D'Antiga, Michele Colledan, Sandro Sironi
PURPOSE: Pediatric liver transplant surgery is burdened by arterial complications whose endovascular treatment is not standardized. We report the outcomes of a cohort of pediatric recipients with hepatic artery complications treated by endoluminal procedures. MATERIALS AND METHODS: From December 2019 to December 2022, consecutive transplanted pediatric patients who underwent endovascular treatment of hepatic artery complications were reviewed. The analysis included: type of complication (occlusion, stenosis, pseudoaneurysm); onset (acute =  < 15 days, subacute = 15-90 days, late =  > 90 days); endovascular technique (angioplasty, stenting); complications and outcomes...
October 13, 2023: Cardiovascular and Interventional Radiology
https://read.qxmd.com/read/37830057/case-report-novel-dguok-variants-associated-with-idiopathic-non-cirrhotic-portal-hypertension-in-a-han-chinese-child
#52
Jia-Qi Li, Jia-Yan Feng, Ying Gong, Wang-Qiang Li, Teng Liu
DGUOK deficiency has primarily been associated with lethal hepatic failure with or without hypotonia, nystagmus, and psychomotor retardation, features typical of mitochondrial disease. A study in 3 Turkish children identified homozygosity for a variant in DGUOK as associated with idiopathic non-cirrhotic portal hypertension (INCPH). However, no further instances of INCPH associated with DGUOK variants have been reported. We here describe a fourth patient with DGUOK variants and childhood-onset INCPH, a 12-year-old Han Chinese boy, reporting clinical manifestations, histopathologic findings, and results of genetic studies...
2023: Frontiers in Pediatrics
https://read.qxmd.com/read/37813556/acute-liver-failure-due-to-hepatitis-a-virus-presented-with-guillain-barr%C3%A3-syndrome-and-ocular-myasthenia-gravis
#53
JOURNAL ARTICLE
Aswanth Ks, Vinod Kumar, Akhil Raj Ms, Nowneet Kumar Bhat
Hepatitis A is one of the most common causes of acute viral hepatitis in children. Immunological manifestations involving the nervous system are rare with hepatitis A infection. We report a case of a toddler who presented with acute liver failure secondary to hepatitis A infection. The child showed clinical and laboratory improvement initially with conservative management. However, after the initial improvement, she developed acute-onset ptosis along with areflexia. Serological and neurophysiological tests revealed the occurrence of ocular variant Guillain-Barré syndrome and ocular myasthenia gravis, which was only partially responsive to treatment (intravenous immunoglobulin and pyridostigmine)...
October 9, 2023: BMJ Case Reports
https://read.qxmd.com/read/37811054/recovery-fulminant-hepatitis-a-in-systemic-juvenile-idiopathic-arthritis-patient-treated-with-tocilizumab-a-case-report
#54
Maysoun Kudsi, Fatima Alghawe, Suaad Hamsho
INTRODUCTION: Systemic juvenile idiopathic arthritis (sJIA) is a rare systemic immune disorder that affects patients before 16 years of age. Several viruses have been reported to trigger this disease. Increased use of biologics, such as tocilizumab and anakinra, and decreased use of glucocorticoid may lead to improved outcomes in patients with sJIA. Serious liver injuries induced by tocilizumab include acute liver failure, hepatitis, and jaundice.Hepatitis A remains a highly prevalent disease in low-income countries...
October 2023: Annals of Medicine and Surgery
https://read.qxmd.com/read/37808908/solved-the-enigma-of-pediatric-severe-acute-hepatitis-of-unknown-origin
#55
REVIEW
Francisco Rodriguez-Frias, Ariadna Rando-Segura, Josep Quer
Hepatitis is an inflammation of the liver whose etiology is very heterogeneous. The most common cause of hepatitis is viral infections from hepatotropic viruses, including hepatitis A, B, C, D and E. However, other factors such as infections from other agents, metabolic disorders, or autoimmune reactions can also contribute to hepatitis, albeit to a lesser extent. On April 5, 2022, the United Kingdom Health Security Agency alerted the World Health Organization (WHO) on the increased incidence of severe acute hepatitis of unknown causes (not A-E) in previously healthy young children, with symptoms of liver failure that in some cases required liver transplantation...
2023: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/37774732/paediatric-acute-hepatitis-of-unknown-aetiology-a-national-surveillance-investigation-in-the-usa-during-2021-and-2022
#56
JOURNAL ARTICLE
Jordan Cates, Julia M Baker, Olivia Almendares, Neha Balachandran, Erin R McKeever, Anita K Kambhampati, Caelin Cubenas, Jan Vinjé, Jennifer L Cannon, Preeti Chhabra, Brandi Freeman, Sarah Reagan-Steiner, Julu Bhatnagar, Paul A Gastañaduy, Hannah L Kirking, David Sugerman, Umesh D Parashar, Jacqueline E Tate
BACKGROUND: Adenovirus is a known cause of hepatitis in immunocompromised children, but not in immunocompetent children. In April, 2022, following multiple reports of hepatitis of unknown aetiology and adenovirus viraemia in immunocompetent children in the USA and UK, the US Centers for Disease Control and Prevention (CDC) and jurisdictional health departments initiated national surveillance of paediatric acute hepatitis of unknown aetiology. We aimed to describe the clinical and epidemiological characteristics of children identified with hepatitis of unknown aetiology between Oct 1, 2021, and Sept 30, 2022, in the USA and to compare characteristics of those who tested positive for adenovirus with those who tested negative...
September 26, 2023: Lancet Child & Adolescent Health
https://read.qxmd.com/read/37756118/severe-acute-hepatitis-of-unknown-etiology-in-a-large-cohort-of-children
#57
JOURNAL ARTICLE
Sagar Mehta, Tomisin John, Jordan J Feld, Hemant Shah, Nisa Mullaithilaga, Aaron Campigotto, Karen Leung, Binita M Kamath, Simon C Ling, Michelle Science, Vicky L Ng
BACKGROUND: We evaluated the proportion, clinical features, and outcomes of previously healthy children presenting to a large Canadian quaternary pediatric center with severe acute hepatitis of unknown etiology. METHODS: All patients with serum alanine aminotransferase (ALT) > 500 U/L or aspartate aminotransferase (AST) > 500 U/L between June 1, 2018, and May 31, 2022, at The Hospital for Sick Children, were identified. Subjects with only AST > 500 U/L were excluded...
October 1, 2023: Hepatology Communications
https://read.qxmd.com/read/37725812/the-role-of-adenovirus-in-hepatitis-of-unknown-etiology-among-children-in-turkey-july-2022-to-january-2023
#58
JOURNAL ARTICLE
Asuman Demirbuğa, Selda Hançerli Törün, Özge Metin-Akcan, Aylin Yücel, Aysun Yahşi, Gülsüm İclal Bayhan, Irmak Emre, Birol Öztürk, Özge Kaba, Günsel Kutluk, Tuğçe Tural-Kara, İrem Ceren Erbaş, Şilem Özdem-Alataş, Mehtap Akça, Berfin Özgökçe-Özmen, Sevgi Aslan, Özlem Çakici
BACKGROUND: In the first half of 2022, the increase in cases of severe acute hepatitis in children with no epidemiological link and unknown cause has aroused concern worldwide. In this study, we aimed to determine the frequency of adenovirus in children with hepatitis of unknown origin in Turkey. METHODS: In this study, which was conducted with the participation of 16 centers from Turkey, between July 2022 and January 2023, 36 pediatric patients under the age of 18 who met the definition of acute hepatitis were included...
September 7, 2023: Pediatric Infectious Disease Journal
https://read.qxmd.com/read/37695715/-association-of-giant-cell-hepatitis-and-autoimmune-hemolytic-anemia-in-infancy
#59
JOURNAL ARTICLE
Katalin Csernus, Alexandra Tészás, Gábor Ottóffy, Antal Dezsőfi-Gottl, András Tárnok
Giant cell hepatitis associated with autoimmune hemolytic anemia (GCH-AIHA) is a rare disorder with unfavorable prognosis, affecting infants and young children. The mortality rate is high, complications of acute liver failure, sepsis, or liver transplantation can be responsible for fatal outcomes. An 18-month-old child who was diagnosed previously with autoimmune hemolytic anemia, developed acute hepatitis and acute liver failure concomitant to the relapse of the disease. GCH-AIHA is characterized by Coombs positive hemolytic anemia and progressive liver injury, histologically defined by widespread giant cell transformation...
September 10, 2023: Orvosi Hetilap
https://read.qxmd.com/read/37692149/acute-infantile-liver-failure-syndrome-type-2-in-a-2-5-year-old-boy-a-case-report
#60
Hosein Shabani-Mirzaee, Fatemeh Sayarifard, Armen Malekiantaghi, Kambiz Eftekhari
KEY CLINICAL MESSAGE: Infantile liver failure type 2 is described as repeated attacks of liver dysfunction with remission. This syndrome should be considered in the differential diagnosis of any child with symptoms of recurrent hepatic encephalopathy. ABSTRACT: Infantile liver failure syndrome 2 is described as recurrent attacks of liver dysfunction. ILFS2 should be included in the differential diagnosis of children with frequent and acute liver failure. We present a 2...
September 2023: Clinical Case Reports
keyword
keyword
163405
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.